Evidence map›Paper›PMID 32848073›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

4-Hydroxyacetophenone modulates the actomyosin cytoskeleton to reduce metastasis.

Darren S Bryan, Melinda Stack, Katarzyna Krysztofiak, Urszula Cichoń, Dustin G Thomas, Alexandra Surcel, Eric S Schiffhauer, Michael A Beckett, Nikolai N Khodarev, Lai Xue and 6 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Non-muscle myosin II is a promising therapeutic target.Trends in pharmacological sciences · 2025
    Article
  7. Article
  8. Article
  9. Ras-mediated dynamic and biphasic regulation of cell migration.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Darren S BryanDepartment of Surgery, The University of Chicago, Chicago, IL 60637.
Melinda StackDepartment of Surgery, The University of Chicago, Chicago, IL 60637.
Katarzyna KrysztofiakBiochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637.
Urszula CichońBiochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637.
Dustin G ThomasDepartment of Cell Biology, Johns Hopkins School of Medicine, Baltimore, MD 21205.
Alexandra SurcelDepartment of Cell Biology, Johns Hopkins School of Medicine, Baltimore, MD 21205.
Eric S SchiffhauerDepartment of Cell Biology, Johns Hopkins School of Medicine, Baltimore, MD 21205.
Michael A BeckettDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637.
Nikolai N KhodarevDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637.
Lai XueDepartment of Surgery, The University of Chicago, Chicago, IL 60637.
Elizabeth C PoliDepartment of Surgery, The University of Chicago, Chicago, IL 60637.
Alexander T PearsonDepartment of Medicine, The University of Chicago, Chicago, IL 60637.
Mitchell C PosnerDepartment of Surgery, The University of Chicago, Chicago, IL 60637.
Douglas N RobinsonDepartment of Cell Biology, Johns Hopkins School of Medicine, Baltimore, MD 21205.ORCID 0000-0003-1236-4891
Ronald S RockBiochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637; rrock@uchicago.edu rrw@radonc.uchicago.edu.ORCID 0000-0003-2188-7272
Ralph R WeichselbaumDepartment of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637; rrock@uchicago.edu rrw@radonc.uchicago.edu.
University of Chicago · USJohns Hopkins University · USJagiellonian University · PL

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI CHIEN-MIN KAO · 1985 to 2026
$122.1M
BIOCHEMISTRY, CELLULAR AND MOLECULAR BIOLOGY PROGRAMT32GM007445 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI GREEN, RACHEL · 1985 to 2021
$24.1M
The Molecular Basis for Myosin Regulation-Equipment SupplementR01GM124272 · NIGMS · UNIVERSITY OF CHICAGO · PI ROCK, RONALD S · 2018 to 2021
$1.4M
Force-sensitive macromolecular cytoskeletal assemblyR01GM109863 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ROBINSON, DOUGLAS N, ROCK, RONALD S · 2014 to 2017
$1.1M
NCI NIH HHS P30 CA014599NIGMS NIH HHS R01 GM109863NIGMS NIH HHS R01 GM124272NIGMS NIH HHS T32 GM007445
6 · The paper itself

Abstract

Metastases are the cause of the vast majority of cancer deaths. In the metastatic process, cells migrate to the vasculature, intravasate, extravasate, and establish metastatic colonies. This pattern of spread requires the cancer cells to change shape and to navigate tissue barriers. Approaches that block this mechanical program represent new therapeutic avenues. We show that 4-hydroxyacetophenone (4-HAP) inhibits colon cancer cell adhesion, invasion, and migration in vitro and reduces the metastatic burden in an in vivo model of colon cancer metastasis to the liver. Treatment with 4-HAP activates nonmuscle myosin-2C (NM2C) (

Indexed as

CytoskeletonAcetophenonesActinsActomyosinAnimalsCell AdhesionCell MovementColorectal NeoplasmsFemaleHCT116 CellsHumansMiceMice, NudeNeoplasm Metastasis4-hydroxyacetophenoneAcetophenonesActinsActomyosin4-hydroxyacetophenonecolorectal cancerex vivo motilitymetastasisnonmuscle myosin 2C

Identifiers

PMID32848073
PMCPMC7486788
OpenAlexW3080474946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.